Advertisement
YOU ARE HERE: LAT HomeCollectionsHealth Industry Manufacturers Association
IN THE NEWS

Health Industry Manufacturers Association

FEATURED ARTICLES
BUSINESS
August 31, 1998 | BARBARA MARSH, TIMES STAFF WRITER
The Health Industry Manufacturers Assn. has lots of favorites on Capitol Hill, and Rep. Christopher Cox is one of them. The Washington-based trade group of biomedical manufacturers likes the way the Newport Beach Republican helped pass legislation last year that's supposed to streamline government regulation of the industry. He serves on the House Commerce Committee, which handled the bill designed to speed up Food and Drug Administration approvals of new medical devices.
ARTICLES BY DATE
BUSINESS
August 31, 1998 | BARBARA MARSH, TIMES STAFF WRITER
The Health Industry Manufacturers Assn. has lots of favorites on Capitol Hill, and Rep. Christopher Cox is one of them. The Washington-based trade group of biomedical manufacturers likes the way the Newport Beach Republican helped pass legislation last year that's supposed to streamline government regulation of the industry. He serves on the House Commerce Committee, which handled the bill designed to speed up Food and Drug Administration approvals of new medical devices.
Advertisement
BUSINESS
December 9, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
A Brussels-based lobbyist told a group of medical device makers this week that, despite uncertainty over ratification of a treaty on closer political union in Western Europe, efforts to set standards for their products will proceed as planned. Paul Adamson, a European Community lobbyist for the Health Industry Manufacturers Assn., said that recent financial and political turmoil surrounding the Maastricht Treaty may ironically benefit U.S. companies by simplifying doing business in Europe.
BUSINESS
December 9, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
A Brussels-based lobbyist told a group of medical device makers this week that, despite uncertainty over ratification of a treaty on closer political union in Western Europe, efforts to set standards for their products will proceed as planned. Paul Adamson, a European Community lobbyist for the Health Industry Manufacturers Assn., said that recent financial and political turmoil surrounding the Maastricht Treaty may ironically benefit U.S. companies by simplifying doing business in Europe.
Los Angeles Times Articles
|